Shuji Uematsu

463 citations
14 papers · 358 indexed · h-index 10
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Liver Disease Diagnosis and Treatment (3 papers)Liver Disease and Transplantation (2 papers)
Partner nations
JapanUnited Kingdom

In The Last Decade

Shuji Uematsu

14 papers receiving 351 citations

Peers

Shuji Uematsu
Comparison fields: 5 of 46
  • Hepatology 147
  • Molecular Biology 111
  • Physiology 110
  • Epidemiology 107
  • Surgery 60
Replace R. Nakashio with:
R. Nakashio Japan
Judit López‐Luque Spain
Anal Desai United States
Tiepeng Li China
Ai‐Min Xu China
Ingrid Lua United States
Te-Sheng Chang Taiwan
Eiko Saijou Japan
Daniel Tippens United States
Chaonong Cai China
Shuji Uematsu relative to R. Nakashio Japan R. Nakashio's profile →
Citations per field
00.5×9.5×
R. Nakashio · 1×
Citations per year

Countries citing papers authored by Shuji Uematsu

Since Specialization
Citations

This map shows the geographic impact of Shuji Uematsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Uematsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Uematsu more than expected).

Fields of papers citing papers by Shuji Uematsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Uematsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Uematsu. The network helps show where Shuji Uematsu may publish in the future.

Co-authorship network of co-authors of Shuji Uematsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuji Uematsu. A scholar is included among the top collaborators of Shuji Uematsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuji Uematsu. Shuji Uematsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 3
2 1
3 12
4 1
5 27
6
Application of radiofrequency ablation for the treatment of metastatic liver cancers.
2
7 12
8 40
9 55
10 25
11 39
12 65
13 67
14 9

About Shuji Uematsu

Shuji Uematsu is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 14 papers that have together received 358 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (147 citations), Aging (13 citations) and Biotechnology (46 citations). Shuji Uematsu has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Kazuhiro Nouso, Harushige Nakatsukasa, Toshihiro Higashi, Naoki Hino, Keigo Yoshida, Yoshiyuki Kobayashi, Takao Tsuji, Yasuyuki Araki, Yasushi Shiratori and Ryoichi Okamoto. Their work appears in journals such as Journal of Clinical Oncology, Hepatology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026